Mortality in children with sickle cell disease in mainland France from 2000 to 2015
Emilie Desselas, Isabelle Thuret, Florentia Kaguelidou, Malika Benkerrou, Mariane de Montalembert, Marie‐Hélène Odièvre, Emmanuelle Lesprit, Éva Rumpler, Arnaud Fontanet, Corinne Pondarré, Valentine Brousse
Abstract
*Were excluded patients with unknown immunization status (n=17) or patients not eligible (n=14) i.e children born before 2000 (date of licensing of PCV7) or who died before 2 months of age; **Were excluded patients with unknown immunization status (n=7) or patients not eligible (n=23) i.e children who died before 24 months ***Were excluded patients with missing data (n=10) More than one disease modifying therapy was possible. % is calculated out of total patients with available data ; PV23: polysaccharidic vaccine 23; PCV 7 or 13: pneumococcal conjugate vaccine 7 or 13; HSCT: hematopoietic stem cell transplantation